1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validation
2.7. Assumptions
and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Molecular Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1.
By Products and
Services (Reagents and Kits, Instruments, Services & Software)
5.2.2.
By Technology
(Polymerase Chain Reaction (PCR), Sequencing, In-situ hybridization, Chips and
microarrays, Mass spectrometry, Others)
5.2.3.
By Application
(Infectious disease, Oncology testing, Genetic testing, Blood screening,
Others)
5.2.4.
By End User
(Hospitals, Academic & Reference Laboratories, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6.
North America Molecular
Diagnostics Market Outlook
6.1.
Market Size &
Forecast
6.1.1.
By Value
6.2.
Market Share &
Forecast
6.2.1.
By Products and
Services
6.2.2.
By Technology
6.2.3.
By Application
6.2.4.
By End User
6.2.5.
By Country
6.3. North America: Country Analysis
6.3.1. United States Molecular Diagnostics Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Products and
Services
6.3.1.2.2.
By Technology
6.3.1.2.3.
By Application
6.3.1.2.4.
By End User
6.3.2. Canada Molecular Diagnostics Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Products and
Services
6.3.2.2.2.
By Technology
6.3.2.2.3.
By Application
6.3.2.2.4.
By End User
6.3.3. Mexico Molecular Diagnostics Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Products and
Services
6.3.3.2.2.
By Technology
6.3.3.2.3.
By Application
6.3.3.2.4.
By End User
7.
Europe Molecular
Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1.
By Products and
Services
7.2.2.
By Technology
7.2.3.
By Application
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Molecular Diagnostics Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Products and
Services
7.3.1.2.2.
By Technology
7.3.1.2.3.
By Application
7.3.1.2.4.
By End User
7.3.2. United Kingdom Molecular Diagnostics Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Products and
Services
7.3.2.2.2.
By Technology
7.3.2.2.3.
By Application
7.3.2.2.4.
By End User
7.3.3. Italy Molecular Diagnostics Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Products and
Services
7.3.3.2.2.
By Technology
7.3.3.2.3.
By Application
7.3.3.2.4.
By End User
7.3.4. France Molecular Diagnostics Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Products and
Services
7.3.4.2.2.
By Technology
7.3.4.2.3.
By Application
7.3.4.2.4.
By End User
7.3.5. Spain Molecular Diagnostics Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Products and
Services
7.3.5.2.2.
By Technology
7.3.5.2.3.
By Application
7.3.5.2.4.
By End User
8.
Asia-Pacific Molecular
Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1.
By Products and
Services
8.2.2.
By Technology
8.2.3.
By Application
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Molecular Diagnostics Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Products and
Services
8.3.1.2.2.
By Technology
8.3.1.2.3.
By Application
8.3.1.2.4.
By End User
8.3.2. India Molecular Diagnostics Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Products and
Services
8.3.2.2.2.
By Technology
8.3.2.2.3.
By Application
8.3.2.2.4.
By End User
8.3.3. Japan Molecular Diagnostics Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Products and
Services
8.3.3.2.2.
By Technology
8.3.3.2.3.
By Application
8.3.3.2.4.
By End User
8.3.4. South Korea Molecular Diagnostics Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Products and
Services
8.3.4.2.2.
By Technology
8.3.4.2.3.
By Application
8.3.4.2.4.
By End User
8.3.5. Australia Molecular Diagnostics Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Products and
Services
8.3.5.2.2.
By Technology
8.3.5.2.3.
By Application
8.3.5.2.4.
By End User
9.
South America Molecular
Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1.
By Products and
Services
9.2.2.
By Technology
9.2.3.
By Application
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Molecular Diagnostics Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Products and
Services
9.3.1.2.2.
By Technology
9.3.1.2.3.
By Application
9.3.1.2.4.
By End User
9.3.2. Argentina Molecular Diagnostics Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Products and
Services
9.3.2.2.2.
By Technology
9.3.2.2.3.
By Application
9.3.2.2.4.
By End User
9.3.3. Colombia Molecular Diagnostics Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Products and
Services
9.3.3.2.2.
By Technology
9.3.3.2.3.
By Application
9.3.3.2.4.
By End User
10.
Middle East and
Africa Molecular Diagnostics Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1.
By Products and
Services
10.2.2.
By Technology
10.2.3.
By Application
10.2.4. By End User
10.2.5. By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa Molecular Diagnostics Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Products and
Services
10.3.1.2.2.
By Technology
10.3.1.2.3.
By Application
10.3.1.2.4.
By End User
10.3.2. Saudi Arabia Molecular Diagnostics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Products and
Services
10.3.2.2.2.
By Technology
10.3.2.2.3.
By Application
10.3.2.2.4.
By End User
10.3.3. UAE Molecular Diagnostics Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Products and
Services
10.3.3.2.2.
By Technology
10.3.3.2.3.
By Application
10.3.3.2.4.
By End User
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13.
Global Molecular Diagnostics Market: SWOT Analysis
14. Competitive Landscape
14.1. F Hoffmann-la Roche Ltd
14.1.1. Business Overview
14.1.2. Product & Service Offerings
14.1.3. Recent Developments
14.1.4. Financials (If Listed)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. Illumina Ltd
14.3. Hologic Corporation
14.4. Agilent Technologies Inc.
14.5. Qiagen NV
14.6. Grifols S.A.
14.7. Becton, Dickinson and Company
14.8. Abbott Laboratories, Inc.
14.9. Biomerieux SA
14.10.Bio-Rad Laboratories Inc.
14.11.Sysmex Corporation
15.
Strategic Recommendations
16.
About Us & Disclaimer